MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
PRLD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Prelude Therapeutics (PRLD) Ownership - Who owns Prelude Therapeutics?

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
175 Innovation Boulevard
Phone
+1 302 467-1280
Employees
79
Web
https://www.preludetx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
312.03M
P/E Ratio
0.88
Total Cash
151.76M
Projected Growth
N/A
Total Debt
17.65M
Revenue
22.42M
Risk (Beta)
2.35
Dividend Yield
N/A
Total Cash/Share
1.90
Total Debt/Equity
N/A
Revenue/Share
0.27 USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
PRLD
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for PRLD
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
175 Innovation Boulevard
Phone
+1 302 467-1280
Employees
79
Web
https://www.preludetx.com